We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.27B
AUM Growth
–
Cap. Flow
+$2.08B
Cap. Flow %
91.71%
Top 10 Hldgs %
60.91%
Holding
226
New
226
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$220M
2
MXIM
Maxim Integrated Products
MXIM
+$217M
3
XLNX
Xilinx Inc
XLNX
+$177M
4
NUAN
Nuance Communications, Inc.
NUAN
+$119M
5
WORK
Slack Technologies, Inc.
WORK
+$108M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Healthcare 18.72%
3 Financials 17.48%
4 Consumer Discretionary 8.17%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STWOW
226
DELISTED
ACON S2 Acquisition Corp Warrant
STWOW
$202K 0.01%
+137,492
New +$157K
6 7 8 9
10

Similar funds

XEA
XN Exponent Advisors New York $2.09B AUM 32.83% 1-Year Est. Return
AIC
Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return
QAM
QCI Asset Management Pittsford, New York $1.72B AUM 25.41% 1-Year Est. Return
BU
BBVA USA Birmingham, Alabama $1.71B AUM
H
Hexavest Montreal, Quebec, Canada $1.64B AUM 28.34% 1-Year Est. Return
FMW
Farr Miller & Washington Washington, District of Columbia $1.53B AUM 32.74% 1-Year Est. Return
MAFM
Mid Atlantic Financial Management Pittsburgh, Pennsylvania $1.49B AUM 24.08% 1-Year Est. Return
BOS
Bingham Osborn & Scarborough San Francisco, California $1.42B AUM 27.88% 1-Year Est. Return

Omni Partners US's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for Omni Partners US, which disclosed 226 positions worth $2.27B. Its ten largest holdings account for 61% of the portfolio.

Its largest position is Alexion Pharmaceuticals: 1,283,115 shares worth $326M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, followed by Healthcare and Financials.

  • Omni Partners US's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,283,115 shares worth $326M.
  • Omni Partners US's ten largest holdings make up 61% of its $2.27B portfolio in Q2 2021.
  • Omni Partners US disclosed 226 positions in Q2 2021, its first 13F filing on record.

Based on Omni Partners US's 13F filing for Q2 2021, filed 16 Aug 2021.